Jinghua Pharmaceutical Group Co., Ltd. (SZSE: 002349)
Health Care · Pharmaceuticals · CN
CN¥6.92
-3.22% today · -11.8% 1Y
Jinghua Pharmaceutical Group Co., Ltd. (SZSE: 002349) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $853.24M and employs 1,462 people.
Over the last twelve months the share price has lost 11.8%, trading between 5.99 and 8.45.
Tweenvest scores Jinghua Pharmaceutical Group Co., Ltd. across four factors: quality 80/100, value 74/100, growth 57/100, dividend 23/100. Its strongest factor is quality.
002349 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $853.24M
- Revenue (TTM)
- $214.02M
- P/E
- 25.44
- EPS
- 0.27
- Dividend yield
- 1.30%
- Beta (5Y)
- 0.12
- 52-week high
- CN¥8.45
- 52-week low
- CN¥5.99
- Avg volume (3M)
- —
- Shares outstanding
- 828.87M
- Employees
- 1,462
- Next earnings
- —
About Jinghua Pharmaceutical Group Co., Ltd.
Established in 1957 and headquartered in Nantong, China, Jinghua Pharmaceutical Group Co., Ltd. is a Chinese enterprise dedicated to the complete process of active pharmaceutical ingredients (APIs) and pharmaceutical intermediates, encompassing their research, development, manufacturing, and distribution. Its essential API offerings include a variety of compounds such as Phenylbutazone, Primidone, Phenobarbital, Fluorouracil, Propylthiouracil, Piroxicam, and Flucytosine. The company previously operated under the name Nantong Jinghua Pharmaceutical Co., Ltd.
- ISIN
- CNE100000L14
- Founded
- 1957
- Listed since
- Feb 3, 2010
- Exchange
- Shenzhen Stock Exchange
- Currency
- CNY
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.12T | $1,255.40 | +0.88% |
| Johnson & JohnsonNYSE: JNJ | $651.25B | $270.24 | +1.07% |
| Merck & Co., Inc.NYSE: MRK | $376.37B | $152.55 | +2.39% |
| Roche Holding AGSWX: ROP | $373.91B | CHF375.60 | +1.02% |
| Novartis AGSWX: NOVN | $302.17B | CHF127.42 | +0.85% |
| AstraZeneca PLCLSE: AZN | $258.76B | £122.40 | +1.26% |
| Novo Nordisk A/SCPSE: NOVO B | $207.84B | Dkr300.85 | +1.59% |
| Pfizer Inc.NYSE: PFE | $159.99B | $28.07 | +1.01% |
Figures last refreshed Aug 18, 2026.